Chemed Corporation
CHE · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $6,507,901 | $7,112,100 | $8,997,209 | $7,869,119 |
| - Cash | $129,752 | $249,904 | $173,882 | $178,350 |
| + Debt | $141,474 | $145,561 | $145,058 | $140,844 |
| Enterprise Value | $6,519,623 | $7,007,757 | $8,968,385 | $7,831,613 |
| Revenue | $624,900 | $618,798 | $646,943 | $639,993 |
| % Growth | 1% | -4.4% | 1.1% | – |
| Gross Profit | $180,673 | $184,693 | $216,413 | $234,118 |
| % Margin | 28.9% | 29.8% | 33.5% | 36.6% |
| EBITDA | $101,779 | $87,818 | $112,020 | $136,453 |
| % Margin | 16.3% | 14.2% | 17.3% | 21.3% |
| Net Income | $64,237 | $52,493 | $71,757 | $90,319 |
| % Margin | 10.3% | 8.5% | 11.1% | 14.1% |
| EPS Diluted | 4.46 | 3.57 | 4.86 | 6.02 |
| % Growth | 24.9% | -26.5% | -19.3% | – |
| Operating Cash Flow | $83,389 | $138,606 | $32,744 | $164,913 |
| Capital Expenditures | -$17,359 | -$15,808 | -$13,280 | -$12,761 |
| Free Cash Flow | $66,030 | $122,798 | $19,464 | $152,152 |